Forsta AP Fonden cut its stake in The Clorox Company (NYSE:CLX – Free Report) by 5.9% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 28,700 shares of the company’s stock after selling 1,800 shares during the period. Forsta AP Fonden’s holdings in Clorox were worth $4,661,000 as of its most recent filing with the Securities and Exchange Commission.
Other large investors have also recently added to or reduced their stakes in the company. Brooklyn Investment Group boosted its position in shares of Clorox by 163.8% during the fourth quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock worth $25,000 after buying an additional 95 shares during the period. Prospera Private Wealth LLC acquired a new position in Clorox during the 3rd quarter worth approximately $27,000. Continuum Advisory LLC grew its stake in shares of Clorox by 300.0% during the 3rd quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock worth $30,000 after acquiring an additional 138 shares in the last quarter. Quarry LP raised its holdings in shares of Clorox by 99.1% in the second quarter. Quarry LP now owns 229 shares of the company’s stock valued at $31,000 after purchasing an additional 114 shares during the last quarter. Finally, Carolina Wealth Advisors LLC bought a new stake in shares of Clorox in the third quarter worth $48,000. Institutional investors own 78.53% of the company’s stock.
Analyst Upgrades and Downgrades
Several equities research analysts have issued reports on CLX shares. StockNews.com lowered shares of Clorox from a “buy” rating to a “hold” rating in a research note on Sunday, January 5th. Royal Bank of Canada reiterated a “sector perform” rating and set a $150.00 target price on shares of Clorox in a report on Thursday. TD Cowen upgraded Clorox from a “sell” rating to a “hold” rating and raised their price target for the company from $155.00 to $170.00 in a research note on Wednesday, November 6th. Barclays dropped their price objective on Clorox from $139.00 to $130.00 and set an “underweight” rating on the stock in a research note on Friday, January 17th. Finally, DA Davidson boosted their target price on shares of Clorox from $153.00 to $171.00 and gave the stock a “neutral” rating in a report on Monday, November 4th. Four investment analysts have rated the stock with a sell rating, eleven have given a hold rating and one has assigned a buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $156.07.
Clorox Price Performance
Clorox stock opened at $158.60 on Friday. The company has a market capitalization of $19.63 billion, a price-to-earnings ratio of 55.26, a PEG ratio of 2.91 and a beta of 0.42. The company has a current ratio of 1.00, a quick ratio of 0.62 and a debt-to-equity ratio of 11.08. The Clorox Company has a 12 month low of $127.60 and a 12 month high of $171.37. The stock’s 50 day moving average is $162.98 and its 200-day moving average is $158.03.
Clorox (NYSE:CLX – Get Free Report) last posted its quarterly earnings data on Wednesday, October 30th. The company reported $1.86 earnings per share for the quarter, topping the consensus estimate of $1.36 by $0.50. The firm had revenue of $1.76 billion for the quarter, compared to analysts’ expectations of $1.64 billion. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The company’s quarterly revenue was up 27.0% compared to the same quarter last year. During the same quarter last year, the business earned $0.49 EPS. Equities research analysts expect that The Clorox Company will post 6.86 EPS for the current year.
Clorox Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Wednesday, January 29th will be paid a $1.22 dividend. This represents a $4.88 annualized dividend and a yield of 3.08%. The ex-dividend date is Wednesday, January 29th. Clorox’s dividend payout ratio (DPR) is 170.04%.
About Clorox
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Featured Stories
- Five stocks we like better than Clorox
- How to Calculate Inflation Rate
- Nebius Group: Market Overreaction or Real AI Disruption?
- What Are Dividends? Buy the Best Dividend Stocks
- The Best Way to Invest in Gold Is…
- Transportation Stocks Investing
- Why Nike Stock Could Be 2025’s Top Comeback Play
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.